Veterinary and Comparative Oncology

Article	Citations
Issue Information	22
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	18
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	17
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours	17
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy	17
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy	15
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours	15
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment	14
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	14
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	13
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	13
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	13
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study	13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping	12
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain	11
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	11
Practice patterns about the role of palliation in veterinary surgical oncology	11
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	11
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin	11
Blood biomarkers for canine cancer, from human to veterinary oncology	11
Issue Information	10
	10
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu	10
Issue Information	9

Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus	9
	9
Cover Image	9
Corrigendum	9
Author Index	9
Issue Information	9
Issue Information	8
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs	8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas	8
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	8
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells	8
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours	7
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs	7
	7
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs	7
	7
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma	7
Frontal sinus carcinoma in forty‐one dogs (2001–2022)	7
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	6
	6
Issue Information	6
	6
Issue Information	6
Issue Information	6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue	6
Author Index	6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma	5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	5
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy	5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire	5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance	5
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma	5
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma	5
Comparison of the anticancer effects of various statins on canine oral melanoma cells	5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs	5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	5
	5
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)	5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases	5
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	5
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma	4
Issue Information	4
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study	4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	4
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience	4

Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study	4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases	4
	4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	4
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission	4
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	4
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”	4
VCS abstract	4
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy	4
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study	4
	4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	3
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma	3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay	3
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas	3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease	3
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins	3
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	3
The animal's microbiome and cancer: A translational perspective	3
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study	3
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	3
	3
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	3
Issue Information	3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours	3
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour	3
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate	3
Axillary lymphadenectomy in dogs: A description of surgical technique	3
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology	2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	2
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas	2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	2
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma	2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy	2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma	2
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies	2
Cover Image	2
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?	2
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases	2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	2
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy	2
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study	2
	2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration	2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	2
Issue Information	2
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas	2
VCS 2024 Abstracts	2
Author Index	2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
Issue Information	2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma	1
Issue Information	1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	1
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate	1
	1
Issue Information	1

An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	1
Issue Information	1
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours	1
Editorial	1
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma	1
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	1
A retrospective analysis of 11 dogs with surface osteosarcoma	1
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	1
Prostaglandin EP4 receptor mRNA expression in canine lymphoma	1
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography	1
	1
Molecular characterization of canine SHP2 mutants and anti‐tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma	1
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution	1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy	1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study	1
Editorial	1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	1
	1
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐118	1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors	1
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer	1
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma	1
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	1
	1
Abstracts	1
Response of canine thyroid carcinomas to radioiodine	1
The prevalence of intra‐tumoral and distant thrombi, as well as tumour‐cell emboli in canine neoplasia	1
Issue Information	1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
	1
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
	1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1